CAL
ICVX

Capital Advisors Ltd’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Capital Advisors Ltd’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-54
Closed – – 1745
2022
Q3 		$0 Buy
+54
New +$338 ﹤0.01% 1606

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Capital Advisors Ltd's ICVX Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2022, closing a stake of 54 shares.

Capital Advisors Ltd first reported a position in ICVX in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 65 funds tracked by Wall St. Rank hold ICVX as of Q4 2022.

  • Capital Advisors Ltd reported no remaining Icosavax, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Capital Advisors Ltd sold 54 Icosavax, Inc. Common Stock shares in Q4 2022.
  • Capital Advisors Ltd first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Capital Advisors Ltd's Icosavax, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.